Please wait a minute...
文章检索
预防医学  2020, Vol. 32 Issue (6): 583-587    DOI: 10.19485/j.cnki.issn2096-5087.2020.06.010
  综述 本期目录 | 过刊浏览 | 高级检索 |
移动信息技术在结核病患者治疗管理中的应用进展
陈馨仪1,综述; 陈彬2, 蒋健敏2,3, 审校
1.宁波大学医学院,浙江 宁波 315211;
2.浙江省疾病预防控制中心;
3.浙江省传染病疫苗与预防控制研究重点实验室
Progress of mobile information technology in treatment and management of tuberculosis
CHEN Xinyi*, CHEN Bin, JIANG Jianmin
*Medical School of Ningbo University,Ningbo,Zhejiang 315211,China
全文: PDF(667 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 针对全球结核病疫情,世界卫生组织提倡采取以医务人员为主对患者开展直接面视下督导治疗服药策略,以保证患者治疗依从性,但其全面落实存在一定的难度。近年来互联网快速发展,一系列可用于结核病健康教育、筛查、诊断、报告和治疗依从性管理的移动信息技术为患者的管理带来了新的契机。本文对移动信息技术应用于结核病患者治疗管理的形式及效果等方面进行综述,为我国推广相关新技术的应用、改善结核病患者治疗依从性提供依据。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
陈馨仪
综述; 陈彬
蒋健敏
审校
关键词 结核病移动医疗药物治疗依从性    
Abstract:In response to the global burden of tuberculosis(TB),the World Health Organization(WHO)has promoted directly observed treatment(DOT)mainly supervised by health care workers to ensure the medication adherence of TB patients. However,there are some difficulties in its full implementation. With the rapid development of the internet in recent years,a series of mobile information technologies that can be used for TB health education,screening,diagnosis,reporting and compliance management have brought new opportunities to the information management of patients. This article reviewed literature about the application and effects of mobile information technology in the treatment and management of TB patients, promoting new technology and improving the medication adherence of TB patients in China.
Key wordstuberculosis    mobile health    medication adherence
收稿日期: 2020-01-09      修回日期: 2020-02-04     
中图分类号:  R521  
基金资助:国家自然科学基金项目(1640019); 浙江省基础公益研究计划项目(LGF19H260004); 浙江省哲学社会科学规划课题(19NDJC243YB); 浙江省医药卫生科技计划项目(2020KY095)
作者简介: 陈馨仪,硕士在读
通信作者: 蒋健敏,E-mail:jmjiang@cdc.zj.cn   
引用本文:   
陈馨仪,综述; 陈彬, 蒋健敏,审校. 移动信息技术在结核病患者治疗管理中的应用进展[J]. 预防医学, 2020, 32(6): 583-587.
CHEN Xinyi, CHEN Bin, JIANG Jianmin. Progress of mobile information technology in treatment and management of tuberculosis. Preventive Medicine, 2020, 32(6): 583-587.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2020.06.010      或      http://www.zjyfyxzz.com/CN/Y2020/V32/I6/583
[1] World Health Organization. Global tuberculosis report2019[EB/OL].(2019-10-17)[2020-02-04].https://www.who.int/tb/publications/global_report/en/.
[2] LIU X Q, LEWIS J J, HUI Z, et al.Effectiveness of electronic reminders to improve medication adherence in tuberculosis patients: a cluster-randomised trial[J]. PLoS Med,2015,12(9):e1001876.
[3] 宋百生. 移动通信信息技术应用及其发展分析[J]. 通讯世界,2019,26(6):57-58.
[4] 章靓,黄钰莹,郭晓芳,等.移动智能医疗系统的现状与挑战[J].海峡药学,2019,31(3):83-285.
[5] 赵利敏,王丽娜.互联网时代移动医疗的现状与发展[J].轻工科技,2018,34(5):97-98.
[6] 周颖, 梅建, 潘秀芳. 信息化管理促进结核病定点医院防治工作开展[J]. 中国防痨杂志,2010,32(6):343-347.
[7] DENKINGER C M,GRENIER J,STRATIS A K, et al.Mobile health to improve tuberculosis care and control: a call worth making[J]. Int J Tuberc Lung Dis,2013,17(6):719-727.
[8] GAO L, QIAN X J, HUANG S Y, et al.The effect of traditional supervision and telephone supervision on treatment compliance of tuberculosis patients in county and township[J]. Int J Epidemiol Infect Dis,2016, 43(6):404-407.
[9] 钱惠军,步佳佳.出院电话随访对肺结核患者服药依从性的影响[J]. 当代护士,2018,25(2):124-125.
[10] MOHAMMED S,GLENNERSTER R,KHAN A J.Impact of a daily SMS medication reminder system on tuberculosis treatment outcomes: a randomized controlled trial[J]. PLoS One,2016,11(11):e0162944.
[11] CHUCK C, ROBINSON E, MACARAIG M, et al.Enhancing management of tuberculosis treatment with video directly observed therapy in New York City[J]. Int J Tuberc Lung Dis,2016, 20(5):588-593.
[12] MBUAGBAW L, THABANE L, ONGOLO-ZOGO P, et al.The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy[J]. PLoS One,2012,7(12):e46909.
[13] LIANG D B, HUANG M Y, LIU F Y, et al.Effect of text message to enhance the management of pulmonary tuberculosis patients[J]. Mod Prev Med,2018,45(5):847-882.
[14] LESTER R, PARK J J, BOLTEN L M, et al.Mobile phone short message service for adherence support and care of patients with tuberculosis infection: evidence and opportunity[J]. J Clin Tuberc Other Mycobact Dis,2019,16:100108.
[15] World Health Organization. Guidelines for the treatment of drug-susceptible tuberculosis and patient care (2017 update). [2020-02-04]. https://www.who.int/tb/publications/2017/dstb_guidance_2017/en/.
[16] DISTEFANO M J, SCHMIDT H.MHealth for tuberculosis treatm-ent adherence: a framework to guide ethical planning, implementation, and evaluation[J]. Glob Health Sci Pract,2016,4(2):211-221.
[17] DEMAIO J, SCHWARTZ L, COOLEY P, et al.The application-of telemedicine technology to a directly observed therapy program for tuberculosis: a pilot project[J]. Clin Infect Dis,2001,33(12):2082-2084.
[18] GARFEIN R S, COLLINS K, MUNOZ F.Feasibility of tubercu-losis treatment monitoring by video directly observed therapy: a binational pilot study[J]. Int J Tuberc Lung Dis,2015,19:1057-1064.
[19] 钟道临, 黄惠安, 刘桂芬, 等. 网络视频直视下督导服药在结核病防治中的应用[J]. 中国医学工程,2012,20(4):143, 145.
[20] MOULDING T, ONSTAD G D, SBARBARO J A.Supervision of outpatient drug therapy with the medication monitor[J]. Ann Intern Med,1970,73(4):559-564.
[21] MOULDING T S.The unrealized potential of the medication monitor[J]. Clin Pharmacol Ther,1979,25(2):131-136.
[22] WILLIAMS A B, FENNIE K P, BOVA C A, et al.Home visits to improve adherence to highly active antiretroviral therapy: a randomized controlled trial[J]. J Acquir Immune Defic Syndr,2006,42(3):314-321.
[23] 彭红, 陆伟, 竺丽梅, 等. 江苏省肺结核患者电子药盒的取药记录与实际服药的一致性研究[J]. 江苏预防医学,2013,24(1):17-20.
[24] 中国疾病预防控制中心. 中盖结核病项目三期在浙江、吉林和宁夏正式启动[EB/OL]. (2016-12-01) [2020-02-04]. http://www.chinacdc.cn/gwswxx/jkzx/201612/t20161201_136213.html.
[25] CHAIYACHATI K H, LOVEDAY M, LORENZ S, et al.A pilot study of an mHealth application for healthcare workers: poor uptake despite high reported acceptability at a rural South African community-based MDR-TB treatment program[J]. PLoS One,2013,8(5):e64662.
[26] 解艳涛, 杜建, 罗萍, 等. 2016 年北京市通州区结核病患者移动督导管理应用程序使用情况初步报告[J]. 中国防痨杂志,2017,39(7):708-712.
[27] LESTER R T, RITVO P, MILLS E J, et al.Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial[J]. Lancet,2010,376(9755):1838-1845.
[28] KUNAWARARAK P, PONGPANICH S,CHANTAWONG S,etal. Tuberculosis treatment with mobile-phone medication reminders in northern Thailand[J]. Southeast Asian J Trop Med Public Health,2011,42(6):1444-1451.
[29] MAHMUD N, RODRIGUEZ J, NESBIT J.A text message-based intervention to bridge the healthcare communication gap in the rural developing world[J]. Technol Health Care,2010,18(2):137-144.
[30] BEDIANG G, STOLL B, ELIA N, et al.SMS reminders to improve adherence and cure of tuberculosis patients in Cameroon (TB-SMS Cameroon): a randomised controlled trial[J]. BMC Public Health,2018,18(1):583-596.
[31] JOHNSON B T, REDDING C A, DICLEMENTE R J, et al.A network-individual-resource model for HIV prevention[J]. AIDS Behav,2010,14(2):204-221.
[32] STORY A, ALDRIDGE R W, SMITH C M, et al.Smartphone-enabled video-observed versus directly observed treatment for tuberc-ulosis: a multicentre, analyst-blinded, randomised, controlled superiority trial[J]. Lancet,2019,393(10177): 1216-1224.
[33] LAM C K, MCGINNIS P K, HAQUE A, et al.Using video technology to increase treatment completion for patients with latent tuberculosis infection on 3-Month isoniazid and rifapentine: an implementation study[J]. J Med Internet Res,2018,20(11): e287.
[34] 徐红, 陆峰. 运用电子药盒管理肺结核患者依从性分析[J]. 江苏预防医学,2013,24(1):51-52.
[35] WANG N,ZHANG H,ZHOU Y,et al.Using electronic medication monitoring to guide differential management of tuberculosis patients at the community level in China[J]. BMC Infect Dis,2019,19(1):844-852.
[36] 王伟, 王晓萌, 柴程良, 等. 浙江省肺结核患者对手机APP健康教育方式的接受状况调查[J]. 医学与社会,2018,31(6): 40-42.
[37] 郑甜, 杨风勤, 孟桂云, 等. 结核病患者延伸服务采用QQ群与电话随访的效果分析[J]. 饮食保健,2017, 4(22): 130-131.
[38] ELANGOVAN R,ARULCHELVAN S.A study on the role of mobile phone communication in tuberculosis DOTS treatment[J]. Indian J Community Med,2013,38(4):229-233.
[39] 吴波. 结核病患者治疗管理新技术的应用与进展[J]. 中国防痨杂志,2019,41(10):1136-1140.
[40] 张金静, 杨云云, 彭大利. 利用新技术提高结核病患者治疗依从性的研究进展[J/OL]. 中国全科医学(2019-06-25) [2020-02-04]. http://kns.cnki.net/kcms/detail/13.1222.R.20190625.1646.014.html.
[41] NGUYEN T A, PHAM M T, NGUYEN T L, et al.Videodirectlyobserved therapy to support adherence with treatment for tuberculosis in Vietnam: a prospective cohort study[J]. Int J Infect Dis,2017,65: 85-89.
[1] 胡嘉, 黄钦, 郑建刚, 何旺瑞, 曾艳文. 江西省居民结核病防治核心信息知晓情况调查[J]. 预防医学, 2023, 35(8): 718-720,731.
[2] 马丽, 梁智超, 陈阳贵, 张为胜, 毛宏凯, 胥婉婷, 曹明芹. 2010—2019年乌鲁木齐市学生结核病病例发现延迟、就诊延迟、确诊延迟分析[J]. 预防医学, 2023, 35(1): 53-56,60.
[3] 夏强, 刘海灿, 赵秀芹, 万康林, 赵丽丽. 结核分枝杆菌异烟肼与乙硫异烟胺交叉耐药的相关基因研究[J]. 预防医学, 2022, 34(8): 836-841.
[4] 马志, 叶尔扎提·吾瓦特, 腾子豪, 蒋远东, 向阳. 2009—2020年伊宁市学生结核病就诊延迟情况调查[J]. 预防医学, 2022, 34(2): 180-184.
[5] 桑国鑫, 陈同, 车洋, 陈云鹏, 贺天锋. 宁波市结核分枝杆菌和艾滋病病毒双重感染筛查结果[J]. 预防医学, 2022, 34(11): 1121-1124.
[6] 腾子豪, 蒋远东, 王玥, 王艳杰, 樊晓蕾, 胡鹏远, 向阳. 新疆某职业院校新生结核潜伏感染的影响因素分析[J]. 预防医学, 2022, 34(11): 1156-1160.
[7] 陈松华. 世界卫生组织关于新冠肺炎流行期间的结核病防控意见[J]. 预防医学, 2021, 33(11): 1187-1188.
[8] 郭海萍, 尚媛媛, 李姗姗, 逄宇. 全基因组测序在结核病分子流行病学研究中的应用[J]. 预防医学, 2020, 32(9): 899-903.
[9] 洪琪, 李锐. 移动医疗APP的风险评估与管理[J]. 预防医学, 2019, 31(6): 637-639.
[10] 贾庆军, 谢立, 吴亦斐, 王乐, 陆敏, 赵刚. 杭州市结核病患者耐药检测结果分析[J]. 预防医学, 2019, 31(3): 289-292.
[11] 潘稚芬, 袁亚芳, 张君丽, 张鹭. 结核分枝杆菌耐多药相关蛋白筛选及诊断价值研究[J]. 预防医学, 2018, 30(12): 1212-1216.
[12] 冯地忠, 何伏华, 陈寿东. 老年结核病患者临床特征分析[J]. 预防医学, 2018, 30(12): 1255-1257.
[13] 胡碧波,傅克本,许亮亮,何丽萍. 应用ARIMA模型预测结核病发病率研究[J]. 预防医学, 2018, 30(10): 1011-1015.
[14] 郝晓刚, 王炜, 陈忠兵. 农村居民结核病防治知识调查[J]. 预防医学, 2017, 29(3): 320-321,324.
[15] 胡嘉, 邱林西, 黄钦, 孟旭, 王健. 贫困地区糖尿病患者中结核病检出率及其影响因素分析[J]. 预防医学, 2016, 28(9): 913-915.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed